Feldman DR - Search Results

1

State-of-the-Art Management of Germ Cell Tumors.

Feldman DR. Feldman DR. Am Soc Clin Oncol Educ Book. 2018 May 23;38:319-323. doi: 10.1200/EDBK_201139. Am Soc Clin Oncol Educ Book. 2018. PMID: 30231334 Free PMC article. Review.

2

Phase II trial of ixabepilone in patients with cisplatin-refractory germ cell tumors.

Feldman DR, Kondagunta GV, Ginsberg MS, Ishill N, Patil S, Cestaro J, Obbens E, Sheinfeld J, Bosl GJ, Motzer RJ. Feldman DR, et al. Invest New Drugs. 2007 Oct;25(5):487-90. doi: 10.1007/s10637-007-9059-2. Epub 2007 May 23. Invest New Drugs. 2007. PMID: 17520176 Clinical Trial.

3

Infectious complications from high-dose chemotherapy and autologous stem cell transplantation for metastatic germ cell tumors.

Jathavedam A, Feldman DR, Ishill N, Turkula S, Patil S, Bosl GJ, Motzer RJ, Weinstock DM. Jathavedam A, et al. Among authors: feldman dr. Biol Blood Marrow Transplant. 2008 May;14(5):595-600. doi: 10.1016/j.bbmt.2008.02.020. Biol Blood Marrow Transplant. 2008. PMID: 18410903 Free article.

4

Good-risk-advanced germ cell tumors: historical perspective and current standards of care.

Feldman DR, Motzer RJ. Feldman DR, et al. World J Urol. 2009 Aug;27(4):463-70. doi: 10.1007/s00345-009-0431-z. Epub 2009 Jun 10. World J Urol. 2009. PMID: 19513721 Review.

5

Phase II trial of sunitinib in patients with relapsed or refractory germ cell tumors.

Feldman DR, Turkula S, Ginsberg MS, Ishill N, Patil S, Carousso M, Bosl GJ, Motzer RJ. Feldman DR, et al. Invest New Drugs. 2010 Aug;28(4):523-8. doi: 10.1007/s10637-009-9280-2. Epub 2009 Jun 23. Invest New Drugs. 2010. PMID: 19547919 Clinical Trial.

6

Identification and validation of a gene expression signature that predicts outcome in adult men with germ cell tumors.

Korkola JE, Houldsworth J, Feldman DR, Olshen AB, Qin LX, Patil S, Reuter VE, Bosl GJ, Chaganti RS. Korkola JE, et al. Among authors: feldman dr. J Clin Oncol. 2009 Nov 1;27(31):5240-7. doi: 10.1200/JCO.2008.20.0386. Epub 2009 Sep 21. J Clin Oncol. 2009. PMID: 19770384 Free PMC article.

7

TI-CE high-dose chemotherapy for patients with previously treated germ cell tumors: results and prognostic factor analysis.

Feldman DR, Sheinfeld J, Bajorin DF, Fischer P, Turkula S, Ishill N, Patil S, Bains M, Reich LM, Bosl GJ, Motzer RJ. Feldman DR, et al. J Clin Oncol. 2010 Apr 1;28(10):1706-13. doi: 10.1200/JCO.2009.25.1561. Epub 2010 Mar 1. J Clin Oncol. 2010. PMID: 20194867 Free PMC article. Clinical Trial.

8

The approach to the patient with synchronous bilateral germ cell tumors: a lesson in oncologic prioritization.

Feldman DR. Feldman DR. Oncology (Williston Park). 2010 Jul;24(8):761-3. Oncology (Williston Park). 2010. PMID: 20718258 Free article. No abstract available.

9

Prognostic factors in patients with metastatic germ cell tumors who experienced treatment failure with cisplatin-based first-line chemotherapy.

International Prognostic Factors Study Group; Lorch A, Beyer J, Bascoul-Mollevi C, Kramar A, Einhorn LH, Necchi A, Massard C, De Giorgi U, Fléchon A, Margolin KA, Lotz JP, Germa Lluch JR, Powles T, Kollmannsberger CK. International Prognostic Factors Study Group, et al. J Clin Oncol. 2010 Nov 20;28(33):4906-11. doi: 10.1200/JCO.2009.26.8128. Epub 2010 Oct 18. J Clin Oncol. 2010. PMID: 20956623

10

Sarcomatoid-variant renal cell carcinoma: treatment outcome and survival in advanced disease.

Molina AM, Tickoo SK, Ishill N, Trinos MJ, Schwartz LH, Patil S, Feldman DR, Reuter VE, Russo P, Motzer RJ. Molina AM, et al. Among authors: feldman dr. Am J Clin Oncol. 2011 Oct;34(5):454-9. doi: 10.1097/COC.0b013e3181f47aa4. Am J Clin Oncol. 2011. PMID: 21127411 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

214 results

Search Page